Visit MILabs at the RSNA 2019
North Hall Level 3, booth #8156
The fastest way to grow your nuclear medicine practice
According to MEDraysintell – market intelligence for the radiation healthcare – growth in nuclear medicine practice is largely driven by radiotheranostics. Radiotherapeutics represented 13% of the global nuclear medicine market in 2017 and are expected to reach 60% by 2030. For further reading click this link.
Direct Dx/Tx imaging at ultra-high resolution
The ability to image any radiotherapy isotope at sub-mm resolution in mice and down to 3 mm resolution in large animals, eliminates the need for indirect Dx/Tx imaging using matched elemental imaging pairs. Even the dualistic Dx/Tx behavior of 124-I, which decays simultaneously by positron emission and electron capture (Auger–) can now be studied at sub-mm resolution in mouse oncology models.
True Translational Theranostic imaging
The stunning spatial and temporal resolutions that can be achieved with MILabs award-winning systems – the VECTor and G-SPECT system for small and large animals respectively – enables translation from small animals to the clinic without image information loss. Reconstructed resolutions are proportionate to the mass of the subjects: from sub-mm for mice to 3 mm for large animals and humans*.
*Clinical and commercial availability for human imaging depends on final local registrations, including FDA and CE clearance
Unlimited targeted radiotherapy tracer choice
MILabs broadband photon tomography technology has been preclinically proven for virtually all isotopes with targeted radiotherapy potential:
Alpha emitters: 209At, 212Pb, 213Bi, 223Ra, 225Ac
Beta emitters: 131I, 177Lu, 188Re
Auger electron emitters: 125I, 123I, 195mPt, 124I
Spotlight on Prof. Albert Sinusas, MD – Yale Medical School An eminent expert in translational cardiovascular research imaging.
Albert J. Sinusas, M.D is Professor of Medicine (Cardiology), Radiology and Biomedical Imaging, at Yale University School of Medicine. He is also Director of the Yale Translational Research Imaging Center, and Director of Advanced Cardiovascular Imaging at Yale New Haven Hospital.
He is a renowned physician in Connecticut where he was nominated in 2019 by his peers as one of the five hundred Best Doctors in America. Dr. Sinusas is also a prominent preclinical researcher with over 200 peer reviewed publications and recipient of the SNM 2008 Hermann Blumgart Award. His research is directed at the applications of non-invasive cardiovascular imaging for the assessment of cardiovascular pathophysiology. Just this year, he co-authored two papers published in Nature.
For further reading on Prof. A. Sinusas’ cutting-edge preclininical imaging work with small and large animals, go to our website.
MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.
Please contact MILabs directly for more information about your local MILabs business partner.